Literature DB >> 8809037

Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor.

J Karow1, K R Hudson, M A Hall, A B Vernallis, J A Taylor, A Gossler, J K Heath.   

Abstract

Interleukin-11 (IL-11) is a polyfunctional cytokine whose biological actions require a specific IL-11 receptor (IL-11R) and the transmembrane transducer gp130. Here we report the production of a soluble form of the murine IL-11R and demonstrate that it interacts with IL-11 ligand with high affinity. The affinity of IL-11 alone for gp130 is below the level of detection, but a complex of IL-11 and soluble IL-11R interacts with gp130 with high affinity. The addition of soluble IL-11R potentiates the effects of exogenous IL-11 in cells that are normally responsive to IL-11. A biological response to IL-11 can be reconstituted in BAF cells transfected with gp130 by addition of IL-11 and soluble IL-11R. These findings show that the cytoplasmic domain of the IL-11R is not required for the biological effects of IL-11 and that a complex of IL-11 and IL-11R mediates signalling by association with gp130.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809037      PMCID: PMC1217647          DOI: 10.1042/bj3180489

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins.

Authors:  A Mackiewicz; H Schooltink; P C Heinrich; S Rose-John
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

Review 2.  Biospecific interaction analysis using biosensor technology.

Authors:  M Malmqvist
Journal:  Nature       Date:  1993-01-14       Impact factor: 49.962

3.  Responsiveness of the interleukin (IL)-6-dependent cell line B9 to IL-11.

Authors:  R Burger; M Gramatzki
Journal:  J Immunol Methods       Date:  1993-01-14       Impact factor: 2.303

4.  Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.

Authors:  J A Lust; K A Donovan; M P Kline; P R Greipp; R A Kyle; N J Maihle
Journal:  Cytokine       Date:  1992-03       Impact factor: 3.861

5.  Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6.

Authors:  H Baumann; P Schendel
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

6.  Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo.

Authors:  M Saito; K Yoshida; M Hibi; T Taga; T Kishimoto
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

7.  c-fos gene induction by interleukin 2: identification of the critical cytoplasmic regions within the interleukin 2 receptor beta chain.

Authors:  M Hatakeyama; A Kawahara; H Mori; H Shibuya; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of alpha 1-protease inhibitor secreted by HepG2 cells.

Authors:  A Mackiewicz; S Rose-John; H Schooltink; M Laciak; A Górny; P C Heinrich
Journal:  FEBS Lett       Date:  1992-07-20       Impact factor: 4.124

9.  Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice.

Authors:  T Y Neben; J Loebelenz; L Hayes; K McCarthy; J Stoudemire; R Schaub; S J Goldman
Journal:  Blood       Date:  1993-02-15       Impact factor: 22.113

10.  Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling.

Authors:  G Paonessa; R Graziani; A De Serio; R Savino; L Ciapponi; A Lahm; A L Salvati; C Toniatti; G Ciliberto
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more
  13 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Birth control vaccine targeting leukemia inhibitory factor.

Authors:  Angela R Lemons; Rajesh K Naz
Journal:  Mol Reprod Dev       Date:  2011-12-02       Impact factor: 2.609

3.  Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice.

Authors:  P Bilinski; D Roopenian; A Gossler
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

4.  Crystal structure of a cytokine-binding region of gp130.

Authors:  J Bravo; D Staunton; J K Heath; E Y Jones
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

5.  Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.

Authors:  H Dahmen; U Horsten; A Küster; Y Jacques; S Minvielle; I M Kerr; G Ciliberto; G Paonessa; P C Heinrich; G Müller-Newen
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

6.  Non-core region modulates interleukin-11 signaling activity: generation of agonist and antagonist variants.

Authors:  Saeko Yanaka; 中冴子 谷; Emiko Sano; 野恵海子 佐; Norio Naruse; 瀬紀男 成; Kin-Ichiro Miura; 浦謹一郎 三; Mutsumi Futatsumori-Sugai; ツ森ー菅井睦美 二; Jose M M Caaveiro; Kouhei Tsumoto; 本浩平 津
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

7.  Two differentially expressed interleukin-11 receptor genes in the mouse genome.

Authors:  P Bilinski; M A Hall; H Neuhaus; C Gissel; J K Heath; A Gossler
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

Review 8.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

9.  Functional characterization of W147A: a high-affinity interleukin-11 antagonist.

Authors:  Nicholas Underhill-Day; Lisa A McGovern; Natalia Karpovich; Helen J Mardon; Victoria A Barton; John K Heath
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

10.  A designer hyper interleukin 11 (H11) is a biologically active cytokine.

Authors:  Hanna Dams-Kozlowska; Katarzyna Gryska; Eliza Kwiatkowska-Borowczyk; Dariusz Izycki; Stefan Rose-John; Andrzej Mackiewicz
Journal:  BMC Biotechnol       Date:  2012-03-21       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.